Purinergic signalling in the pancreas in health and disease

    1. I Novak1
    1. University College Medical School, Autonomic Neuroscience Centre, Rowland Hill Street, London NW3 2PF, UK
      1Molecular and Integrative Physiology, Department of Biology, University of Copenhagen, August Krogh Building, Universitetsparken 13, DK 2100 Copenhagen Ø, Denmark
    1. (Correspondence should be addressed to G Burnstock; Email: g.burnstock{at}ucl.ac.uk)

    Abstract

    Pancreatic cells contain specialised stores for ATP. Purinergic receptors (P2 and P1) and ecto-nucleotidases are expressed in both endocrine and exocrine calls, as well as in stromal cells. The pancreas, especially the endocrine cells, were an early target for the actions of ATP. After the historical perspective of purinergic signalling in the pancreas, the focus of this review will be the physiological functions of purinergic signalling in the regulation of both endocrine and exocrine pancreas. Next, we will consider possible interaction between purinergic signalling and other regulatory systems and their relation to nutrient homeostasis and cell survival. The pancreas is an organ exhibiting several serious diseases – cystic fibrosis, pancreatitis, pancreatic cancer and diabetes – and some are associated with changes in life-style and are increasing in incidence. There is upcoming evidence for the role of purinergic signalling in the pathophysiology of the pancreas, and the new challenge is to understand how it is integrated with other pathological processes.

    • Received in final form 20 February 2012
    • Accepted 6 March 2012
    • Made available online as an Accepted Preprint 6 March 2012
    | Table of Contents